Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care Progyny (NASDAQ:PGNY) marks its 10-year anniversary on April 1, 2026, celebrating growth in women’s health and family building benefits.The company highlights support for over 470,000 members, more than 600 employers, coverage of 7.2 million lives, and data-driven clinical outcomes improving IVF and menopause access.

#PGNY Progyny Commemorates 10 Years of Redefining Women’s Health and Family Building Care

www.stocktitan.net/news/PGNY/progyny-commem...

Progyny, Inc. Announces Fourth Quarter 2025 Results Progyny (Nasdaq: PGNY) reported 4Q2025 revenue $318.4M (+6.7% YoY) and FY2025 revenue $1.2887B (+10% YoY). Gross profit was $76.9M in 4Q and $304.5M for FY. Net income was $12.5M (4Q) and $58.5M (FY). Adjusted EBITDA was $51.4M (4Q) and $222.1M (FY).The company generated $210.2M operating cash flow in 2025, repurchased ~6.5M shares (~$160M), ended year with no debt and ~555 clients.

#PGNY Progyny, Inc. Announces Fourth Quarter 2025 Results

www.stocktitan.net/news/PGNY/progyny-inc-an...

Progyny, Inc. Announces Third Quarter 2025 Results Progyny (Nasdaq: PGNY) reported 3Q 2025 revenue of $313.3M, up 9.3% year-over-year (or +23% excluding a large non-renewing client). The company posted gross profit $72.8M (+23%), net income $13.9M ($0.15 diluted) and Adjusted EBITDA $55.0M (+18%) with a 17.5% Adjusted EBITDA margin.Key operational items include ~80 new clients adding ~900,000 lives, near 100% client retention for 2026, ~553 clients and average members ~6.76M. Cash flow was strong with $156.0M operating cash flow for the first nine months and cash & equivalents of $345.2M. The board authorized up to $200M for share repurchases and the company raised full-year 2025 guidance to revenue of $1.263B–$1.278B.

#PGNY Progyny, Inc. Announces Third Quarter 2025 Results

www.stocktitan.net/news/PGNY/progyny-inc-an...

Transcarent Experience Store Expansion: More Options for Women’s Health Transcarent (PGNY) expanded its Experience Store on October 21, 2025 by adding three women’s health partners — Maven Clinic, Midi Health, and Progyny — to existing partners Carrot and Kindbody, aiming to centralize fertility, family-building, perimenopause and menopause care for Members.The WayFinding™ generative-AI experience offers single sign-on, consolidated reporting, and measurable outcomes; Transcarent cites 7.6x more referrals to women’s health and a 10–20% increase in point-solution utilization when fragmentation is reduced.

#PGNY Transcarent Experience Store Expansion: More Options for Women’s Health

www.stocktitan.net/news/PGNY/transcarent-ex...

Progyny CEO Named World Economic Forum Champion for Women’s Health Progyny (Nasdaq: PGNY) announced that CEO Pete Anevski was named a Champion for Women’s Health by the World Economic Forum and the Global Alliance for Women’s Health on October 7, 2025.Anevski joins a global community of leaders committed to advocacy, policy, research, innovation, and investment to close care gaps in women’s health. Progyny said Chief Medical Officer Dr. Janet Choi also participated in GAWH workgroups on maternal health and women’s health science. The company said it will engage in Forum platforms and initiatives to promote research and scalable solutions across governments, investors, and industries worldwide.

#PGNY Progyny CEO Named World Economic Forum Champion for Women’s Health

www.stocktitan.net/news/PGNY/progyny-ceo-na...

Progyny ($PGNY) shines in Q1. Revenue climbs, patient numbers rise, and employer partnerships expand. Is fertility benefits the new growth frontier?
Read more 👉 buff.ly/4vD8lqx
#PGNY #FemTech #HealthBenefits #ValueTheMarkets

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause Progyny (Nasdaq: PGNY) has announced a strategic partnership with ŌURA, a leading smart ring manufacturer, to enhance women's health monitoring and care from preconception through menopause. The collaboration will integrate ŌURA's wearable technology data into Progyny's healthcare ecosystem starting in early 2026.The partnership aims to provide comprehensive health tracking capabilities, including sleep patterns, cycle insights, cardiovascular health, and stress levels. This data integration will enable earlier risk identification and support various health goals, particularly in fertility planning and menopause management. The initiative will be available to Progyny's client base, including employers and health plans.

#PGNY Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause

www.stocktitan.net/news/PGNY/progyny-partne...

Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report Progyny (NASDAQ: PGNY), a leader in women's health and family building solutions, has secured a new $200 million revolving credit facility maturing on July 1, 2030. The undrawn facility enhances the company's operational and financial flexibility, though there are no immediate plans for its use.The company anticipates Q2 2025 financial results to exceed previous guidance due to favorable member activity. Revenue, Adjusted net income, and Adjusted EBITDA are expected to surpass the ranges provided in May. Progyny will report detailed Q2 2025 results on August 7, 2025, after market close.The company maintains its capital priorities, including potential stock repurchases, product portfolio expansion, investments in distribution channels, and strategic acquisitions.

#PGNY Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report

www.stocktitan.net/news/PGNY/progyny-inc-pr...

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health Progyny (NASDAQ: PGNY), a leader in women's health solutions, has announced the addition of pelvic floor therapy to its comprehensive healthcare offerings. The expansion includes partnerships with Origin for in-person and virtual physical therapy, and Hinge Health for digital care solutions.The initiative addresses a significant healthcare gap, as one in three women experience pelvic floor issues, with 20% requiring surgery. The program aims to provide early intervention and comprehensive care through specialty-trained providers, potentially reducing the $20 billion annual healthcare costs associated with urinary incontinence alone.

#PGNY Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health

www.stocktitan.net/news/PGNY/progyny-adds-p...

Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution Progyny (NASDAQ: PGNY), a leading women's health and family building solutions provider, has joined Amazon's Health Benefits Connector program as its first comprehensive women's health provider. This collaboration enables eligible Amazon customers to discover and enroll in Progyny's fertility, family building, and menopause benefits through their employers or health plans. Progyny currently serves over 530 employers and health plans, reaching more than 6.7 million lives with its clinically integrated care model. The partnership aims to address the issue that nearly 25% of U.S. adults face in understanding their available health benefits. Through Amazon's platform, users can easily verify their Progyny coverage and access personalized support with just a few clicks.

#PGNY Progyny Joins Amazon’s Health Benefits Connector Program as First Women’s Health and Family Building Solution

www.stocktitan.net/news/PGNY/progyny-joins-...

Progyny, Inc. Announces First Quarter 2025 Results Progyny (PGNY) reported strong Q1 2025 financial results with record revenue of $324.0 million, up 16.5% year-over-year. The company's performance was driven by client and covered lives growth. Gross profit increased 21% to $75.8 million, with gross margin improving to 23.4%. Net income was $15.1 million ($0.17 per diluted share), while Adjusted EBITDA grew 15% to $57.8 million. The company expanded to 532 fertility and family building clients, up from 451 in Q1 2024. Based on strong Q1 performance, Progyny raised its full-year 2025 guidance, projecting revenue between $1.185-$1.235 billion. The company maintains a strong financial position with $256.1 million in cash and no debt.

#PGNY Progyny, Inc. Announces First Quarter 2025 Results

www.stocktitan.net/news/PGNY/progyny-inc-an...

Progyny Reports Strong Q4 Revenue Growth But Signals Potential Slowdown Ahead - What's Behind the Numbers? Fertility benefits provider grows client base by 20.7% to 473, generates $52.2M quarterly cash flow, but projects slower 1-5% growth for 2025.

#PGNY Progyny, Inc. Announces Fourth Quarter 2024 Results

www.stocktitan.net/news/PGNY/progyny-inc-an...

Earnings Alert: Progyny Sets Date for 2024 Annual Results - Key Details for Investors Progyny announces Q4 and FY2024 earnings release on February 27, followed by conference call. Access details for investors and replay options available.

#PGNY Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2024 Results Report

www.stocktitan.net/news/PGNY/progyny-inc-an...

Game-Changing Parental Benefits Deal: Progyny Just Solved Working Parents' Biggest Challenge Progyny acquires BenefitBump to revolutionize parental leave support, addressing 90% of working parents' needs with comprehensive family building and wellness services.

#PGNY Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump

www.stocktitan.net/news/PGNY/progyny-inc-en...

Progyny Raises Q4 Guidance as Member Activity Strengthens, CEO to Present at JPM Conference Fertility benefits leader Progyny reports improved Q4 treatment volumes and expects to exceed previous revenue and earnings guidance. CEO Anevski to present outlook at JPM Healthcare.

#PGNY Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference

www.stocktitan.net/news/PGNY/progyny-to-dis...

#PGNY Progyny, Inc. to Present at Jefferies London Healthcare Conference

www.stocktitan.net/news/PGNY/progyny-inc-to...

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#SAVE, #HNRG, #PGNY, #CVE, #ASAN

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #MVST 6.3x
2. #RKLB 3.0x
3. #SAVE 2.6x
4. #HNRG 2.2x
5. #PGNY 2.0x

#OptionFlow #OptionsTrading #Trading

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#PSTG, #WT, #SKIN, #PGNY, #RVPH

#OptionFlow #OptionsTrading #Trading

Breaking News: ( NASDAQ: #PGNY ) Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Progyny, Inc. (PGNY) And Encourages Investors to Reach Out

#StockMarket #News